Following its recent clearance in key European markets, ACE-031 1mg is facing significant uptake. Market data indicate a positive reception among healthcare professionals , particularly in France . Obstacles surrounding reimbursement remain, and are presently being tackled by the developer through planned discussions with payers . The initial marke